top of page
Where KEM® Outperforms
In early-phase clinical development, especially, in late-pre-clinical, phase-1 and phase-2 stages, heterogeneity is the norm.
Traditional statistical approaches often lack the resolution to identify signals within 'Fat Data': datasets with limited patient cohorts but massive descriptor density.
The Power
of Logical AI
KEM® identifies rules that remain consistent across patient populations, rather than seeking simple statistical correlation.
Built for Fat Data
Optimized for trials with as few
as 5–10 patients and extreme descriptor density
Fully Explainable
KEM® delivers a certain, interpretable answer: native explainability, not a black box
Finds Rare
Signals
Designed specifically to surface rare but clinically critical patterns that large-dataset methods are structurally unable to detect.
bottom of page